Task based profiles of language impairment in Parkinson’s Disease
Objective: This study aimed to add to our understanding of language impairment in people with Parkinson's Disease (PwPD). Background: Language difficulties are increasingly reported in…Improved verb use in Parkinson’s disease following intensive voice treatment
Objective: To identify changes in language production secondary to voice treatment in speakers with Parkinson’s disease (PD). Background: Given the role of voice in language…Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus
Objective: Identifying the risk factors of dementia in patients with both Parkinson’s disease (PD) and type 2 diabetes mellitus (DM) (PD-DM) is clinically relevant and…The ADNPC-RS: a risk score that identifies Lewy body disease individuals at risk for developing concomitant Alzheimer’s pathology
Objective: To identify which common genetic variants that confer risk for Alzheimer’s disease (AD) also predict the development of concomitant AD pathology in patients with…Survival in Parkinson’s Disease and Association with MAPT and APOE
Objective: To assess survival in a large cohort of Parkinson's disease (PD) patients, and to determine if survival correlates with MAPT and APOE gene variants.…Human induced pluripotent stem cells (iPSCs) as a model for the study of neural development in Parkinson’s Disease patients carrying GBA mutations
Objective: The aim of this study is to evaluate in vitro development of human induced pluripotent stem cells (iPSCs) [1] derived from fibroblasts of Parkinson’s…Characterizing Global Cohorts with Monogenic Parkinson’s Disease
Objective: To clinically and genetically characterize a global sample of subjects with monogenic Parkinson’s disease (mPD) and unaffected mutation carriers. Background: Publications on patients with…Auxilin knockout mice: a model for Parkinsonism with dopamine dysregulation and synucleinopathy
Objective: To evaluate the role of auxilin in the pathogenesis of Parkinson’s disease (PD). Background: Auxilin or DNAJC6, a brain-specific co-chaperone plays central role in…Is it time to consider circulating microRNAs as a diagnostic biomarker in REM sleep behavior disorder?
Objective: To detect the expression of two circulating microRNAs (miRNAs) in patients with REM sleep behavior disorder (RBD) compared to patients with Parkinson´s Disease (PD).…Spatiotemporal Changes in Substantia Nigra Neuromelanin Content from Prodromal to Clinical Parkinson’s Disease
Objective: To investigate the voxel-wise spatiotemporal changes in neuromelanin-sensitive MRI (NM-MRI) signal in the substantia nigra and their relation to clinical scores of disease severity…
- « Previous Page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- …
- 149
- Next Page »